Hand-held Dental X-ray System (HyperLight-M)
Changzhou Sifary Medical Technology Co., Ltd. · Decision date Sep 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 09/14/2026 for the Hand-held Dental X-ray System (HyperLight-M), submitted by Changzhou Sifary Medical Technology Co., Ltd. of Changzhou, CN, under 510(k) number K260795. The device falls under regulation 872.1800, classification product code EHD, with Dental as the regulation medical specialty and Radiology as the review panel. The application was received 03/11/2026 and is a Traditional 510(k) not reviewed by a third party.
SESE denotes 510(k) clearance, not premarket approval. The applicant's own submission states its conclusion that the device is safe and effective and substantially equivalent to a predicate device as described; the public record reviewed here does not identify that predicate, the technological characteristics compared, or any performance testing. The page lists no combination product and no authorized Predetermined Change Control Plan. No summary statement content or clinical data were available in the retrieved material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260795
- Regulatory pathway
- 510(k) premarket notification
- Product code
- EHD
- Decision code
- SESE
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Unit, X-Ray, Extraoral With Timer.
- Product code
- EHD
- FDA device class
- 2
FDA decision timeline
K260795 received
Application receipt date recorded by FDA.
K260795 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Changzhou Sifary Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Changzhou
Sources and methodology
- Original FDA record: K260795
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records